🏥Public HealthFDA Leadership Uncertainty Follows Withdrawal of Commissioner Nominee
The White House has withdrawn Heidi Overton’s nomination for FDA commissioner, leaving the agency without a permanent leader and facing significant policy hurdles.
🏥Public HealthThe White House has withdrawn Heidi Overton’s nomination for FDA commissioner, leaving the agency without a permanent leader and facing significant policy hurdles.
❤️Conditions & CareThe FDA has introduced new label warnings for GLP-1 medications regarding a rare form of vision loss, leaving patients and physicians to weigh the benefits of treatment a…
❤️Conditions & CareThe FDA has approved adrabetadex to treat infantile-onset Niemann-Pick disease type C, a rare and fatal genetic condition characterized by the buildup of cholesterol in b…
🥗NutritionAs lab-grown meat gains traction on social media alongside growing misinformation, nutrition and science experts break down what cultivated meat actually is and how it is…
🧠AI AnalysisThe U.S. Food and Drug Administration has approved Sunharbo as the first factor XIa inhibitor to help prevent secondary strokes when combined with antiplatelet therapy.
🧠AI AnalysisThe U.S. Food and Drug Administration has granted accelerated approval to Rybrevant Faspro for adults with advanced head and neck squamous cell carcinoma.
🧠AI AnalysisThe White House has pulled the nomination of Heidi Overton, MD, PhD, for FDA commissioner after it became clear she lacked the necessary votes in the Senate.
🏥Public HealthThe Trump administration has pulled Heidi Overton's nomination to head the Food and Drug Administration following a lack of support on the Senate health panel.
❤️Conditions & CareThe FDA has granted accelerated approval to neladalkib for advanced ALK-positive non-small cell lung cancer patients who have undergone prior treatments.
🧠Mind & Mental HealthThe FDA has initiated proceedings to remove FloLipid, a liquid form of the statin simvastatin, from the market after the manufacturer repeatedly failed to submit mandator…
❤️Conditions & CareFederal regulators have approved a new once-daily pill combination for adults with advanced hormone receptor-positive breast cancer that has progressed despite previous h…
🏥Public HealthThe nomination of Heidi Overton for Food and Drug Commissioner has exposed internal Republican divisions over vaping regulations, complicating confirmation efforts during…
🧠Mind & Mental HealthFederal regulators have approved giredestrant paired with everolimus for specific types of advanced breast cancer following positive clinical trial data.
🧠AI AnalysisRecent health reports highlight serious conditions linked to GLP-1 receptor agonists, updated HIPAA response timelines for providers, and new FDA approvals for home-use m…
❤️Conditions & CareFederal regulators have approved a novel antipsychotic medication called Cobenfy, marking a significant shift from decades-old dopamine-targeting treatments.
🧠AI AnalysisThe Food and Drug Administration has cleared Roche's new oral therapy Wilserdly for specific advanced breast cancer patients, marking an important regulatory milestone fo…
🧠AI AnalysisFederal regulators have turned down an application for the investigational cancer treatment ivonescimab, pointing to a lack of statistically significant overall survival …
🧠AI AnalysisThe U.S. Food and Drug Administration has introduced a new legal designation for N-acetyl-L-cysteine (NAC) to resolve years of regulatory uncertainty surrounding its sale…
Federal officials have closed the investigation into an E. coli O26 outbreak tied to raw milk cheese after 18 people across 10 states fell ill. Nine individuals were hosp…
🧠AI AnalysisThe FDA has approved obinutuzumab for primary membranous nephropathy, marking the first time a dedicated drug has been authorized for this rare autoimmune kidney conditio…
🧠AI AnalysisFederal regulators have turned down an application for ivonescimab, an experimental lung cancer therapy invented in China and licensed by a U.S. firm, citing insufficient…
🧠Mind & Mental HealthRegulatory authorities have turned down the lung cancer therapy ivonescimab, developed by Summit Therapeutics and Akeso, citing a lack of demonstrated overall survival be…
❤️Conditions & CareFederal regulators have approved a new injectable nanobody, gefurulimab, for adults with anti-AChR antibody-positive generalized myasthenia gravis following positive phas…
❤️Conditions & CareBoston Scientific continues to heavily promote its Watchman heart implant following years of intense regulatory debate and a narrow initial FDA approval.
❤️Conditions & CareExperts have published practical recommendations for using the immunotherapy drug teplizumab in children and adolescents newly diagnosed with stage 3 type 1 diabetes.
🔬ResearchThe U.S. Food and Drug Administration has issued a safety communication warning of a potential link between GLP-1 receptor agonists and a rare, permanent vision condition…
❤️Conditions & CareA new analysis from US Food and Drug Administration researchers examines thirty years of adeno-associated virus gene therapy Investigational New Drug submissions, offerin…
🏃FitnessWhile U.S. health officials have advanced several popular peptides for compounding, an advisory committee voted to keep emideltide, also known as DSIP, restricted due to …
Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.